Record ID | ia:immunopotentiati0000symp |
Source | Internet Archive |
Download MARC XML | https://archive.org/download/immunopotentiati0000symp/immunopotentiati0000symp_marc.xml |
Download MARC binary | https://www.archive.org/download/immunopotentiati0000symp/immunopotentiati0000symp_meta.mrc |
LEADER: 05566cam 2200925 a 4500
001 ocm00809870
003 OCoLC
005 20221118004035.0
008 740422s1973 ne a b 101 0 eng
010 $a 73084990
040 $aDLC$beng$cDLC$dDNB$dNLM$dOCL$dOCLCQ$dMUQ$dBTCTA$dOKU$dDEBBG$dBDX$dOCLCO$dOCLCF$dOCLCQ$dOCLCO$dOCLCQ$dOCL$dOCLCO$dOCLCQ$dOCLCO$dGILDS$dOCLCO$dOCLCA$dAGL$dOCLCO$dOCL
016 7 $a0402764$2DNLM
019 $a1137087$a38244502
020 $a0444150153$q(American Elsevier)
020 $a9780444150158$q(American Elsevier)
020 $a9021940191
020 $a9789021940199
035 $a(OCoLC)809870$z(OCoLC)1137087$z(OCoLC)38244502
050 00 $aQR187.3$b.S95 1973
060 00 $aW3$bC161F v.18 1973
060 10 $aQW 920$bS9893i 1973
070 $aQR180.3.S92 1973
082 00 $a574.2/9
084 $aWF 9800$2rvk
111 2 $aSymposium on Immunopotentiation$d(1973 :$cLondon, England)
245 10 $aImmunopotentiation.
260 $aAmsterdam ;$aNew York :$bElsevier :$bAssociated Scientific,$c1973.
300 $aix, 355 pages :$billustrations ;$c25 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aCiba Foundation symposium ;$v18 (new ser.)
500 $aProceedings of the Symposium on Immunopotentiation, held at the Ciba Foundation, 18th-19th Jan. 1973.
500 $aEditors: G.E.W. Wolstenholme and Julie Knight.
504 $aIncludes bibliographical references and indexes.
505 0 $aThe cellular targets for the action of adjuvants : T-adjuvants and B-adjuvants / D.W. Dresser, Jennifer M. Phillips -- The relation of lymphocyte trapping to the mode of action of adjuvants / P. Frost, E.M. Lance -- Immunopotentiation by Mycobacteria in complete Freund-type adjuvant as the failure of normal immunological homeostasis / R.G. White -- Effects of adjuvants on different cell types and their interactions in immune responses / A.C. Allison -- Cellular mechanisms underlying the adjuvant activity of Corynebacterium parvum : interactions of activated macrophages with T and B lymphocytes / James G. Howard, Martin T. Scott, George H. Christie -- Chemotaxis of macrophages : the role of a macro phage-specific cytotaxin from anaerobic corynebacteria and its relation to immunopotentiation in vivo / P.C. Wilkinson, G.J. O'Neill, R.J. McInroy, J.C. Cater, J.A. Roberts -- The allogeneic effect on the immune system and its potential application to tumour immunity / David H. Katz -- Mitogens as probes for immunocyte regulation : specific and non-specific suppression of B cell mitogenesis / Wesley W. Bullock, Jan Andersson -- The use of viruses as immunological potentiators / J. Lindenmann -- Corynebacterium parvum, a potent immunostimulant in experimental infections and in malignancies / B. Halpern, A. Fray, Y. Crepin, O. Platica, A.M. Lorinet, A. Rabourdin, L. Sparros, R. Isac -- Orchidectomy as a method of immunopotentiation in mice / J.E. Castro, P.B. Medawar, D.N.H. Hamilton -- The nature of immunopotentiation by the anti-tumour polysaccharide lentinan and the significance of biogenic amines in its action / Yukiko Y. Maeda, Jungi Hamuro, Yoko O. Yamada, Kazuko Ishimura, Goro Chihara -- The effect of Corynebacterium parvum and other reticuloendothelial stimulants on transplanted tumours in mice / M.F.A. Woodruff, Noreen Dunbar -- Attempt at using systemic immunity adjuvants in experimental and human cancer therapy / G. Mathé.
650 0 $aImmunological adjuvants$vCongresses.
650 0 $aTumors$xImmunological aspects$vCongresses.
650 0 $aImmunological adjuvants.
650 0 $aImmunosuppression.
650 0 $aImmunosuppression$vCongresses.
650 0 $aCancer$xImmunological aspects$xCongresses.
650 2 $aAdjuvants, Immunologic
650 2 $aImmunosuppression Therapy
650 2 $aNeoplasms$ximmunology
650 6 $aAdjuvants immunologiques.
650 6 $aImmunosuppression$vCongrès.
650 6 $aCancer$xImmunologie$xCongrès.
650 6 $aAdjuvants immunologiques$vCongrès.
650 6 $aTumeurs$xImmunologie$vCongrès.
650 6 $aImmunosuppression.
650 7 $aImmunosuppression.$2fast$0(OCoLC)fst00968033
650 7 $aCancer$xImmunological aspects.$2fast$0(OCoLC)fst00845383
650 7 $aImmunological adjuvants.$2fast$0(OCoLC)fst00967992
650 7 $aTumors$xImmunological aspects.$2fast$0(OCoLC)fst01158775
655 2 $aCongress
655 4 $aCongresses.
655 7 $aConference papers and proceedings.$2fast$0(OCoLC)fst01423772
655 7 $aConference papers and proceedings.$2lcgft
655 7 $aActes de congrès.$2rvmgf
655 7 $aImmunopotentiation.$2swd
700 1 $aWolstenholme, G. E. W.$q(Gordon Ethelbert Ward)
700 1 $aKnight, Julie.
710 2 $aCiba Foundation.
776 08 $iOnline version:$aSymposium on Immunopotentiation (1973 : London, England).$tImmunopotentiation.$dAmsterdam, New York, Elsevier, 1973$w(OCoLC)599539541
830 0 $aCiba Foundation symposium ;$vnew ser. 18.
938 $aBrodart$bBROD$n27883116$c$25.00
938 $aBaker and Taylor$bBTCP$n73084990
029 1 $aAU@$b000000525059
029 1 $aAU@$b000044121908
029 1 $aDEBBG$bBV001955706
029 1 $aDEBSZ$b004007689
029 1 $aHR0$b9021940191
029 1 $aNLGGC$b822480751
029 1 $aNLM$b0402764
029 1 $aNZ1$b3792595
029 1 $aZWZ$b045543895
029 1 $aAU@$b000057993528
994 $aZ0$bGTX
948 $hNO HOLDINGS IN GTX - 238 OTHER HOLDINGS